Target intelligence / Profile preview

Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHA1)

Target
PDHA1
Molecular classification
Enzyme (specifically mitochondrial oxidoreductase), Member of the pyruvate dehydrogenase complex family
01

Overview

The pyruvate dehydrogenase E1 alpha subunit is encoded by the PDHA1 gene on the X chromosome. It forms part of the heterotetrameric E1 enzyme (with two alpha and two beta subunits), which catalyzes the critical conversion of pyruvate to acetyl-CoA, initiating the TCA cycle and driving cellular respiration. Mutations in this subunit disrupt mitochondrial energy metabolism, leading to inherited metabolic disorders such as PDC deficiency, characterized by lactic acidosis and neurological symptoms[1][3][7]. It is also mechanistically implicated in cancer cell metabolism and serves as a potential pharmacological target in metabolic modulation therapies[2][7].

Other names
PDH E1 alpha subunitPyruvate dehydrogenase (lipoamide) alpha 1PDHA1E1-alphaODPA_HUMAN
02

Mechanism of action

Dichloroacetate: inhibits pyruvate dehydrogenase kinase, thus activating the pyruvate dehydrogenase complex Thiamine supplementation: increases cofactor affinity in deficiency states

03

Biological functions

Oxidative decarboxylation of pyruvate to acetyl-CoALinking glycolysis and the tricarboxylic acid (TCA) cycleATP production via aerobic respiration
04

Disease associations

Pyruvate dehydrogenase complex deficiency (PDC deficiency)Neurological disorders (including neurodegeneration and lactic acidosis)Possibly cancer metabolism (role in cancer cell survival is under investigation)
05

Safety considerations

Risk of lactic acidosis if PDHA1 activity is deficientNeurological impairment due to mitochondrial dysfunction in deficiencyDrug safety dependent on mitochondrial and metabolic status
06

Interacting drugs

Dichloroacetate (DCA, investigational, targets PDH complex by inhibiting its phosphorylation and activating it)

1 more in the full profile.

07

Biomarkers

Pyruvate/lactate ratio (used in diagnosis of PDH complex deficiency)Enzymatic activity measurements in blood or tissue

Beyond the preview

Go deeper on Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call